Trial Profile
A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome for Treatment of Invasive Aspergillosis (IA).
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 Apr 2014
Price :
$35
*
At a glance
- Drugs Anidulafungin (Primary) ; Amphotericin B
- Indications Aspergillosis; Invasive bronchopulmonary aspergillosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer; Vicuron Pharmaceuticals
- 17 Apr 2014 New trial record